Vitamin Shoppe VSI released its Q2 results before the open on Wednesday. Earnings per share came in below Wall Street consensus expectations, however shares traded up 2.55 percent due to the company's beat on sales estimates.
Vitamin Shoppe reported EPS of $0.55 and revenues of $332.7 million. Analyst consensus had an EPS estimate of $0.59 and revenues of $331.6 million.
"First quarter results reflect growth in ecommerce sales and improvement in gross margins partially offset by lower retail comparable sales growth. During the quarter we made considerable progress with our reinvention plan as we rolled out some key initiatives which include: an improved loyalty program, new customer acquisition tools and buy online/pick up in store capabilities" stated Colin Watts, CEO.
"In order to help fund our initiatives, we engaged a consulting firm to help us identify opportunities to improve margins and reduce costs. We are in the early stages of introducing many new and exciting initiatives to enhance our overall customer experience, which we expect will start delivering benefits as the year progresses" stated Watts.
Share Buybacks
"We continued with our share buyback program, re-purchasing 1.7 million of our common shares, or 6% of the shares outstanding, in the quarter," noted Watts.
Market News and Data brought to you by Benzinga APIsShare Buybacks
"We continued with our share buyback program, re-purchasing 1.7 million of our common shares, or 6% of the shares outstanding, in the quarter," noted Watts.
Guidance
Company management saw FY16 EPS at $2.10-$2.30 vs. $2.32 estimates.
At the time of writing, Vitamin Shoppe traded at $29.00 in Wednesday's pre-market session, up 2.55 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in